Sulfinpyrazone

Generic name: Pronounced as (sul fin peer' a zone)
Brand names
  • Anturane®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 06/15/2017

Sulfinpyrazone is no longer available in the United States. If you are currently using sulfinpyrazone, you should call your doctor to discuss switching to another treatment.

Sulfinpyrazone is used to treat gouty arthritis. It works by lowering the amount of uric acid in your blood, preventing gout attacks. The drug helps prevent attacks but will not treat an attack once it has started.

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Sulfinpyrazone comes as a tablet and capsule to take by mouth. Sulfinpyrazone usually is taken twice a day. Take with food or milk. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take sulfinpyrazone exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Sulfinpyrazone helps control gout but does not cure it. Continue to take sulfinpyrazone even if you feel well. Do not stop taking sulfinpyrazone without talking to your doctor.

Sulfinpyrazone may be used after a heart attack. Talk to your doctor about the possible risks of using this drug for your condition.

Before taking sulfinpyrazone,

  • tell your doctor and pharmacist if you are allergic to sulfinpyrazone or any other drugs.

  • tell your doctor and pharmacist what prescription and nonprescription medications you are taking, especially anticoagulants ('blood thinners') such as warfarin (Coumadin), acetaminophen (Tylenol), aspirin or products that contain aspirin, cholestyramine (Questran), diuretics ('water pills'), niacin (Nicobid, Slo-Niacin), theophylline (Theo-Dur), tolbutamide (Orinase), verapamil (Calan, Isoptin), and vitamins.

  • tell your doctor if you have or have ever had peptic ulcer disease, kidney disease, or any blood disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking sulfinpyrazone, call your doctor.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking sulfinpyrazone.

  • you should know that this drug may make you drowsy. Do not drive a car or operate machinery until you know how this drug affects you.

  • remember that alcohol can add to the drowsiness caused by this drug. Also, alcohol may increase the amount of uric acid in your blood. Do not drink alcohol while taking sulfinpyrazone before checking with your doctor.

Sulfinpyrazone helps your body get rid of uric acid through your urine. This process may cause kidney stones. To help prevent kidney stones, be sure to drink 10 to 12 glasses (8 ounces [240 milliliters] each) of fluid each day or drink enough water to keep your urine a light yellow color.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Sulfinpyrazone may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • nausea

    • vomiting

    • loss of appetite

    • joint pain, redness, or swelling

  • If you experience any of the following symptoms, call your doctor immediately:

    • difficulty breathing

    • tightness in the chest

    • skin rash

    • unusual bruising or bleeding

    • fever

    • sore throat

    • mouth sores

    • swollen or painful glands

    • painful urination

    • change in the amount of urine

    • lower back or side pain

    • blood in urine or stool

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your response to sulfinpyrazone.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Repaglinide Repaglinide The metabolism of Repaglinide can be decreased when combined with Sulfinpyrazone.
Montelukast Montelukast The metabolism of Montelukast can be decreased when combined with Sulfinpyrazone.
Leflunomide Leflunomide The metabolism of Leflunomide can be decreased when combined with Sulfinpyrazone.
Nevirapine Nevirapine The metabolism of Nevirapine can be decreased when combined with Sulfinpyrazone.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Sulfinpyrazone.
Aminophylline Aminophylline The metabolism of Aminophylline can be increased when combined with Sulfinpyrazone.
Anagrelide Anagrelide Anagrelide may increase the antiplatelet activities of Sulfinpyrazone.
Candesartan Candesartan The metabolism of Candesartan can be decreased when combined with Sulfinpyrazone.
Cilostazol Cilostazol Sulfinpyrazone may increase the antiplatelet activities of Cilostazol.
Clopidogrel Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Sulfinpyrazone.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole Erythromycin may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Fenofibrate Fenofibrate The metabolism of Sulfinpyrazone can be increased when combined with Fenofibrate.
Olsalazine Olsalazine The risk or severity of bleeding can be increased when Olsalazine is combined with Sulfinpyrazone.
Paregoric Paregoric The metabolism of Morphine can be decreased when combined with Sulfinpyrazone.
Reserpine Reserpine Reserpine may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Tacrolimus Tacrolimus The metabolism of Tacrolimus can be increased when combined with Sulfinpyrazone.
Hydromorphone Injection Hydromorphone Injection The metabolism of Hydromorphone can be decreased when combined with Sulfinpyrazone.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Interferon beta-1b.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Interferon gamma-1b.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be increased when combined with Sulfinpyrazone.
Morphine Injection Morphine Injection The metabolism of Morphine can be decreased when combined with Sulfinpyrazone.
Zidovudine Injection Zidovudine Injection The metabolism of Zidovudine can be decreased when combined with Sulfinpyrazone.
Altretamine Altretamine The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Sulfinpyrazone.
Cyclosporine Cyclosporine The serum concentration of Cyclosporine can be decreased when it is combined with Sulfinpyrazone.
Ondansetron Ondansetron The metabolism of Ondansetron can be decreased when combined with Sulfinpyrazone.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Enoxaparin.
Torsemide Torsemide The metabolism of Torasemide can be decreased when combined with Sulfinpyrazone.
Alosetron Alosetron The metabolism of Alosetron can be decreased when combined with Sulfinpyrazone.
Dofetilide Dofetilide The metabolism of Dofetilide can be increased when combined with Sulfinpyrazone.
Hydroxychloroquine Hydroxychloroquine The metabolism of Hydroxychloroquine can be decreased when combined with Sulfinpyrazone.
Meloxicam Meloxicam The risk or severity of bleeding can be increased when Meloxicam is combined with Sulfinpyrazone.
Telmisartan Telmisartan Telmisartan may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Temozolomide Temozolomide The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Temozolomide.
Linezolid Linezolid The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Sulfinpyrazone.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of adverse effects can be increased when Pentosan polysulfate is combined with Sulfinpyrazone.
Trimipramine Trimipramine The metabolism of Trimipramine can be decreased when combined with Sulfinpyrazone.
Tenofovir Tenofovir The metabolism of Tenofovir can be increased when combined with Sulfinpyrazone.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The risk or severity of bleeding can be increased when Choline magnesium trisalicylate is combined with Sulfinpyrazone.
Sirolimus Sirolimus The metabolism of Sirolimus can be increased when combined with Sulfinpyrazone.
Epirubicin Epirubicin The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Epirubicin.
Escitalopram Escitalopram The risk or severity of bleeding can be increased when Escitalopram is combined with Sulfinpyrazone.
Olmesartan Olmesartan Olmesartan may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be increased when combined with Sulfinpyrazone.
Ezetimibe Ezetimibe Ezetimibe may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Atazanavir Atazanavir The metabolism of Atazanavir can be increased when combined with Sulfinpyrazone.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Sulfinpyrazone.
Eletriptan Eletriptan The metabolism of Eletriptan can be decreased when combined with Sulfinpyrazone.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Sulfinpyrazone.
Progesterone Progesterone Progesterone may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Apomorphine Injection Apomorphine Injection The metabolism of Apomorphine can be decreased when combined with Sulfinpyrazone.
Duloxetine Duloxetine Duloxetine may increase the antiplatelet activities of Sulfinpyrazone.
Norethindrone Norethindrone The metabolism of Norethisterone can be increased when combined with Sulfinpyrazone.
Tinidazole Tinidazole Tinidazole may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Bosentan Bosentan Bosentan may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Erlotinib Erlotinib The serum concentration of Erlotinib can be decreased when it is combined with Sulfinpyrazone.
Eszopiclone Eszopiclone The serum concentration of Eszopiclone can be decreased when it is combined with Sulfinpyrazone.
Voriconazole Voriconazole The metabolism of Voriconazole can be decreased when combined with Sulfinpyrazone.
Dextroamphetamine Dextroamphetamine The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Sulfinpyrazone.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Peginterferon alfa-2a.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Peginterferon alfa-2b.
Isocarboxazid Isocarboxazid The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Sulfinpyrazone.
Ramelteon Ramelteon The metabolism of Ramelteon can be decreased when combined with Sulfinpyrazone.
Tipranavir Tipranavir Tipranavir may increase the antiplatelet activities of Sulfinpyrazone.
Ranolazine Ranolazine The metabolism of Sulfinpyrazone can be increased when combined with Ranolazine.
Rasagiline Rasagiline The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Sulfinpyrazone.
Imatinib Imatinib The metabolism of Imatinib can be decreased when combined with Sulfinpyrazone.
Sitagliptin Sitagliptin The metabolism of Sitagliptin can be decreased when combined with Sulfinpyrazone.
Bortezomib Bortezomib The metabolism of Bortezomib can be increased when combined with Sulfinpyrazone.
Clofarabine Injection Clofarabine Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Clofarabine.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Oxaliplatin.
Rituximab Injection Rituximab Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Rituximab.
Bismuth Subsalicylate Bismuth Subsalicylate The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Bismuth subsalicylate.
Pemetrexed Injection Pemetrexed Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Pemetrexed.
Retapamulin Retapamulin The metabolism of Retapamulin can be increased when combined with Sulfinpyrazone.
Vorinostat Vorinostat The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Vorinostat.
Sorafenib Sorafenib The metabolism of Sorafenib can be increased when combined with Sulfinpyrazone.
Sunitinib Sunitinib The metabolism of Sunitinib can be increased when combined with Sulfinpyrazone.
Dronabinol Dronabinol The metabolism of Dronabinol can be decreased when combined with Sulfinpyrazone.
Lapatinib Lapatinib The metabolism of Lapatinib can be decreased when combined with Sulfinpyrazone.
Dasatinib Dasatinib Dasatinib may increase the anticoagulant activities of Sulfinpyrazone.
Mexiletine Mexiletine The metabolism of Mexiletine can be increased when combined with Sulfinpyrazone.
Omega-3 Fatty Acids Omega-3 Fatty Acids Omega-3 fatty acids may increase the antiplatelet activities of Sulfinpyrazone.
Azacitidine Injection Azacitidine Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Azacitidine.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be increased when combined with Sulfinpyrazone.
Nelarabine Injection Nelarabine Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Nelarabine.
Lenalidomide Lenalidomide The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Lenalidomide.
Nilotinib Nilotinib The metabolism of Nilotinib can be increased when combined with Sulfinpyrazone.
Bexarotene Bexarotene The metabolism of Bexarotene can be decreased when combined with Sulfinpyrazone.
Budesonide Budesonide Sulfinpyrazone may decrease the excretion rate of Budesonide which could result in a higher serum level.
Chloramphenicol Injection Chloramphenicol Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Chloramphenicol.
Decitabine Injection Decitabine Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Decitabine.
Etravirine Etravirine The metabolism of Etravirine can be decreased when combined with Sulfinpyrazone.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Sulfinpyrazone.
Tretinoin Tretinoin The metabolism of Tretinoin can be decreased when combined with Sulfinpyrazone.
Bendamustine Injection Bendamustine Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Bendamustine.
Ixabepilone Injection Ixabepilone Injection The metabolism of Ixabepilone can be increased when combined with Sulfinpyrazone.
Irinotecan Injection Irinotecan Injection The metabolism of Irinotecan can be increased when combined with Sulfinpyrazone.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Alemtuzumab.
Rufinamide Rufinamide The metabolism of Rufinamide can be increased when combined with Sulfinpyrazone.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Dexrazoxane.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Sulfinpyrazone.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Ibritumomab tiuxetan.
Milnacipran Milnacipran The metabolism of Milnacipran can be increased when combined with Sulfinpyrazone.
Prasugrel Prasugrel The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Prasugrel.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Sulfinpyrazone.
Everolimus Everolimus The metabolism of Everolimus can be increased when combined with Sulfinpyrazone.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be increased when combined with Sulfinpyrazone.
Dronedarone Dronedarone The metabolism of Dronedarone can be increased when combined with Sulfinpyrazone.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be increased when combined with Sulfinpyrazone.
Tapentadol Tapentadol The metabolism of Tapentadol can be decreased when combined with Sulfinpyrazone.
Topotecan Topotecan The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Topotecan.
Pazopanib Pazopanib The metabolism of Pazopanib can be increased when combined with Sulfinpyrazone.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Sulfinpyrazone.
Albendazole Albendazole The metabolism of Albendazole can be increased when combined with Sulfinpyrazone.
Ulipristal Ulipristal The metabolism of Ulipristal can be increased when combined with Sulfinpyrazone.
Levonorgestrel Levonorgestrel The metabolism of Levonorgestrel can be increased when combined with Sulfinpyrazone.
Dabigatran Dabigatran The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Dabigatran.
Eribulin Injection Eribulin Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be increased when combined with Sulfinpyrazone.
Pegloticase Injection Pegloticase Injection The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Pegloticase.
Denileukin Diftitox Injection Denileukin Diftitox Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Aldesleukin.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be increased when combined with Sulfinpyrazone.
Roflumilast Roflumilast The metabolism of Roflumilast can be increased when combined with Sulfinpyrazone.
Linagliptin Linagliptin The metabolism of Linagliptin can be increased when combined with Sulfinpyrazone.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cyclophosphamide can be increased when combined with Sulfinpyrazone.
Rivaroxaban Rivaroxaban Sulfinpyrazone may increase the anticoagulant activities of Rivaroxaban.
Ticagrelor Ticagrelor The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be increased when combined with Sulfinpyrazone.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be increased when combined with Sulfinpyrazone.
Vandetanib Vandetanib The metabolism of Vandetanib can be increased when combined with Sulfinpyrazone.
Clobazam Clobazam The metabolism of Clobazam can be increased when combined with Sulfinpyrazone.
Vemurafenib Vemurafenib The metabolism of Vemurafenib can be increased when combined with Sulfinpyrazone.
Vismodegib Vismodegib The metabolism of Vismodegib can be decreased when combined with Sulfinpyrazone.
Axitinib Axitinib The metabolism of Axitinib can be increased when combined with Sulfinpyrazone.
Crizotinib Crizotinib The metabolism of Crizotinib can be increased when combined with Sulfinpyrazone.
Melphalan Injection Melphalan Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Melphalan.
Cabergoline Cabergoline The metabolism of Cabergoline can be increased when combined with Sulfinpyrazone.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Fondaparinux.
Carfilzomib Injection Carfilzomib Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Carfilzomib.
Iloprost Iloprost The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Iloprost.
Enzalutamide Enzalutamide The metabolism of Enzalutamide can be decreased when combined with Sulfinpyrazone.
Regorafenib Regorafenib The metabolism of Regorafenib can be increased when combined with Sulfinpyrazone.
Bosutinib Bosutinib The metabolism of Bosutinib can be increased when combined with Sulfinpyrazone.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Sulfinpyrazone.
Icosapent Ethyl Icosapent Ethyl Sulfinpyrazone may increase the antiplatelet activities of Icosapent ethyl.
Tofacitinib Tofacitinib The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Tofacitinib.
Ponatinib Ponatinib The metabolism of Ponatinib can be increased when combined with Sulfinpyrazone.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be increased when combined with Sulfinpyrazone.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be increased when combined with Sulfinpyrazone.
Apixaban Apixaban The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Apixaban.
Dabrafenib Dabrafenib The metabolism of Sulfinpyrazone can be increased when combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Sulfinpyrazone.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be increased when combined with Sulfinpyrazone.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Sulfinpyrazone.
Perampanel Perampanel The metabolism of Perampanel can be increased when combined with Sulfinpyrazone.
Ibrutinib Ibrutinib The risk or severity of adverse effects can be increased when Ibrutinib is combined with Sulfinpyrazone.
Lomitapide Lomitapide The metabolism of Lomitapide can be increased when combined with Sulfinpyrazone.
Ketorolac Injection Ketorolac Injection The risk or severity of bleeding can be increased when Ketorolac is combined with Sulfinpyrazone.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Obinutuzumab.
Simeprevir Simeprevir Simeprevir may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Sulfinpyrazone.
Ceritinib Ceritinib The metabolism of Sulfinpyrazone can be increased when combined with Ceritinib.
Belinostat Injection Belinostat Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Belinostat.
Idelalisib Idelalisib The metabolism of Idelalisib can be increased when combined with Sulfinpyrazone.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be decreased when combined with Sulfinpyrazone.
Vorapaxar Vorapaxar The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Vorapaxar.
Hydrocodone Hydrocodone The metabolism of Hydrocodone can be increased when combined with Sulfinpyrazone.
Suvorexant Suvorexant The metabolism of Suvorexant can be increased when combined with Sulfinpyrazone.
Edoxaban Edoxaban The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Edoxaban.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Olaparib can be increased when combined with Sulfinpyrazone.
Blinatumomab Injection Blinatumomab Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Blinatumomab.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be increased when combined with Sulfinpyrazone.
Riociguat Riociguat The metabolism of Riociguat can be decreased when combined with Sulfinpyrazone.
Nintedanib Nintedanib The metabolism of Nintedanib can be increased when combined with Sulfinpyrazone.
Palbociclib Palbociclib The metabolism of Palbociclib can be increased when combined with Sulfinpyrazone.
Lenvatinib Lenvatinib Lenvatinib may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Panobinostat Panobinostat The metabolism of Panobinostat can be increased when combined with Sulfinpyrazone.
Dinutuximab Injection Dinutuximab Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Sulfinpyrazone.
Deoxycholic Acid Injection Deoxycholic Acid Injection The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Deoxycholic acid.
Sonidegib Sonidegib The metabolism of Sonidegib can be increased when combined with Sulfinpyrazone.
Ziprasidone Injection Ziprasidone Injection The metabolism of Ziprasidone can be increased when combined with Sulfinpyrazone.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be increased when combined with Sulfinpyrazone.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be increased when combined with Sulfinpyrazone.
Osimertinib Osimertinib The metabolism of Osimertinib can be increased when combined with Sulfinpyrazone.
Alectinib Alectinib The metabolism of Alectinib can be increased when combined with Sulfinpyrazone.
Ixazomib Ixazomib The metabolism of Ixazomib can be increased when combined with Sulfinpyrazone.
Lesinurad Lesinurad The metabolism of Lesinurad can be decreased when combined with Sulfinpyrazone.
Dexamethasone Injection Dexamethasone Injection Dexamethasone may increase the excretion rate of Sulfinpyrazone which could result in a lower serum level and potentially a reduction in efficacy.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Defibrotide.
Brivaracetam Injection Brivaracetam Injection The metabolism of Brivaracetam can be decreased when combined with Sulfinpyrazone.
Venetoclax Venetoclax The metabolism of Venetoclax can be increased when combined with Sulfinpyrazone.
Selexipag Selexipag The metabolism of Selexipag can be decreased when combined with Sulfinpyrazone.
Obeticholic Acid Obeticholic Acid The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Obeticholic acid.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Diphenhydramine can be decreased when combined with Sulfinpyrazone.
Ribociclib Ribociclib The metabolism of Ribociclib can be increased when combined with Sulfinpyrazone.
Brigatinib Brigatinib The metabolism of Brigatinib can be increased when combined with Sulfinpyrazone.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Sulfinpyrazone.
Safinamide Safinamide The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Sulfinpyrazone.
Midostaurin Midostaurin The metabolism of Midostaurin can be increased when combined with Sulfinpyrazone.
Neratinib Neratinib The metabolism of Neratinib can be increased when combined with Sulfinpyrazone.
Enasidenib Enasidenib The metabolism of Enasidenib can be increased when combined with Sulfinpyrazone.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be increased when combined with Sulfinpyrazone.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be increased when combined with Sulfinpyrazone.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be increased when combined with Sulfinpyrazone.
Betrixaban Betrixaban The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Betrixaban.
Acalabrutinib Acalabrutinib The metabolism of Acalabrutinib can be increased when combined with Sulfinpyrazone.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Gemtuzumab ozogamicin.
Letermovir Letermovir Letermovir may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Sulfinpyrazone.
Apalutamide Apalutamide The metabolism of Apalutamide can be decreased when combined with Sulfinpyrazone.
Penicillamine Penicillamine The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Penicillamine.
Baricitinib Baricitinib The metabolism of Baricitinib can be increased when combined with Sulfinpyrazone.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be increased when combined with Sulfinpyrazone.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Sulfinpyrazone.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Sulfinpyrazone.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be increased when combined with Sulfinpyrazone.
Duvelisib Duvelisib The metabolism of Duvelisib can be increased when combined with Sulfinpyrazone.
Gilteritinib Gilteritinib The metabolism of Gilteritinib can be increased when combined with Sulfinpyrazone.
Glasdegib Glasdegib The metabolism of Glasdegib can be decreased when combined with Sulfinpyrazone.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Sulfinpyrazone.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be increased when combined with Sulfinpyrazone.
Prucalopride Prucalopride The metabolism of Prucalopride can be increased when combined with Sulfinpyrazone.
Siponimod Siponimod The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Siponimod.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection Sulfinpyrazone may increase the antiplatelet activities of Caplacizumab.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be increased when combined with Sulfinpyrazone.
Alpelisib Alpelisib The metabolism of Sulfinpyrazone can be increased when combined with Alpelisib.
Cladribine Cladribine The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Cladribine.
Triclabendazole Triclabendazole The metabolism of Triclabendazole can be decreased when combined with Sulfinpyrazone.
Entrectinib Entrectinib The metabolism of Entrectinib can be increased when combined with Sulfinpyrazone.
Pexidartinib Pexidartinib The metabolism of Pexidartinib can be increased when combined with Sulfinpyrazone.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Sulfinpyrazone.
Pitolisant Pitolisant The serum concentration of Sulfinpyrazone can be decreased when it is combined with Pitolisant.
Lefamulin Lefamulin The metabolism of Lefamulin can be increased when combined with Sulfinpyrazone.
Phenytoin Injection Phenytoin Injection The metabolism of Phenytoin can be decreased when combined with Sulfinpyrazone.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Sulfinpyrazone.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be increased when combined with Sulfinpyrazone.
Voxelotor Voxelotor The metabolism of Voxelotor can be decreased when combined with Sulfinpyrazone.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Sulfinpyrazone.
Lumateperone Lumateperone The serum concentration of Lumateperone can be decreased when it is combined with Sulfinpyrazone.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be increased when combined with Sulfinpyrazone.
Cenobamate Cenobamate The serum concentration of Cenobamate can be decreased when it is combined with Sulfinpyrazone.
Ozanimod Ozanimod The metabolism of Ozanimod can be decreased when combined with Sulfinpyrazone.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Sulfinpyrazone.
Rimegepant Rimegepant The metabolism of Rimegepant can be increased when combined with Sulfinpyrazone.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Sulfinpyrazone.
Selpercatinib Selpercatinib The serum concentration of Selpercatinib can be decreased when it is combined with Sulfinpyrazone.
Capmatinib Capmatinib The serum concentration of Capmatinib can be decreased when it is combined with Sulfinpyrazone.
Lemborexant Lemborexant The serum concentration of Lemborexant can be decreased when it is combined with Sulfinpyrazone.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection Sulfinpyrazone may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Pralsetinib Pralsetinib Pralsetinib may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Sulfinpyrazone can be decreased when it is combined with Satralizumab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Drospirenone can be increased when combined with Sulfinpyrazone.
Vitamin E (Alpha-Tocopherol) Vitamin E (Alpha-Tocopherol) Vitamin E may increase the antiplatelet activities of Sulfinpyrazone.
Theophylline Theophylline The metabolism of Theophylline can be increased when combined with Sulfinpyrazone.
Fenoprofen Fenoprofen The risk or severity of bleeding can be increased when Fenoprofen is combined with Sulfinpyrazone.
Indomethacin Indomethacin The risk or severity of bleeding can be increased when Indomethacin is combined with Sulfinpyrazone.
Mefenamic Acid Mefenamic Acid The risk or severity of bleeding can be increased when Mefenamic acid is combined with Sulfinpyrazone.
Naproxen Naproxen The risk or severity of bleeding can be increased when Naproxen is combined with Sulfinpyrazone.
Tolmetin Tolmetin The risk or severity of bleeding can be increased when Tolmetin is combined with Sulfinpyrazone.
Sulindac Sulindac The risk or severity of bleeding can be increased when Sulindac is combined with Sulfinpyrazone.
Trazodone Trazodone The risk or severity of bleeding can be increased when Trazodone is combined with Sulfinpyrazone.
Hydroxyurea Hydroxyurea The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Hydroxyurea.
Floxuridine Floxuridine The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Floxuridine.
Phenobarbital Phenobarbital The metabolism of Phenobarbital can be decreased when combined with Sulfinpyrazone.
Methotrexate Injection Methotrexate Injection The metabolism of Methotrexate can be increased when combined with Sulfinpyrazone.
Primidone Primidone The metabolism of Primidone can be decreased when combined with Sulfinpyrazone.
Chlorpromazine Chlorpromazine Chlorpromazine may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Diazepam Diazepam The metabolism of Diazepam can be decreased when combined with Sulfinpyrazone.
Lorazepam Lorazepam The metabolism of Lorazepam can be increased when combined with Sulfinpyrazone.
Carmustine Carmustine The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Carmustine.
Tranylcypromine Tranylcypromine The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Sulfinpyrazone.
Phenelzine Phenelzine The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Sulfinpyrazone.
Procarbazine Procarbazine The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Sulfinpyrazone.
Thioguanine Thioguanine The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Tioguanine.
Prochlorperazine Prochlorperazine The metabolism of Prochlorperazine can be increased when combined with Sulfinpyrazone.
Dapsone Dapsone The metabolism of Dapsone can be decreased when combined with Sulfinpyrazone.
Sulfadiazine Sulfadiazine The metabolism of Sulfadiazine can be decreased when combined with Sulfinpyrazone.
Methadone Methadone The metabolism of Methadone can be decreased when combined with Sulfinpyrazone.
Ibuprofen Ibuprofen The risk or severity of bleeding can be increased when Ibuprofen is combined with Sulfinpyrazone.
Phentermine Phentermine The metabolism of Phentermine can be increased when combined with Sulfinpyrazone.
Sulfasalazine Sulfasalazine The risk or severity of bleeding can be increased when Sulfasalazine is combined with Sulfinpyrazone.
Lomustine Lomustine The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Lomustine.
Doxorubicin Doxorubicin The metabolism of Sulfinpyrazone can be increased when combined with Doxorubicin.
Cytarabine Cytarabine The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Cytarabine.
Mechlorethamine Mechlorethamine The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Mechlorethamine.
Dactinomycin Dactinomycin The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Dactinomycin.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be increased when combined with Sulfinpyrazone.
Clonidine Clonidine The metabolism of Clonidine can be increased when combined with Sulfinpyrazone.
Cimetidine Cimetidine Cimetidine may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Warfarin Warfarin The metabolism of Warfarin can be increased when combined with Sulfinpyrazone.
Clonazepam Clonazepam The metabolism of Clonazepam can be increased when combined with Sulfinpyrazone.
Loperamide Loperamide The metabolism of Loperamide can be decreased when combined with Sulfinpyrazone.
Promethazine Promethazine The metabolism of Promethazine can be increased when combined with Sulfinpyrazone.
Meclofenamate Meclofenamate The risk or severity of bleeding can be increased when Meclofenamic acid is combined with Sulfinpyrazone.
Daunorubicin Daunorubicin Sulfinpyrazone may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin The serum concentration of Nitrofurantoin can be increased when it is combined with Sulfinpyrazone.
Digoxin Digoxin Sulfinpyrazone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chloroquine Chloroquine The metabolism of Chloroquine can be decreased when combined with Sulfinpyrazone.
Quinine Quinine The metabolism of Quinine can be decreased when combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide The therapeutic efficacy of Sulfinpyrazone can be decreased when used in combination with Chlorothiazide.
Isosorbide Isosorbide The metabolism of Isosorbide can be increased when combined with Sulfinpyrazone.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be increased when combined with Sulfinpyrazone.
Desipramine Desipramine The metabolism of Desipramine can be increased when combined with Sulfinpyrazone.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Sulfinpyrazone.
Imipramine Imipramine The metabolism of Imipramine can be increased when combined with Sulfinpyrazone.
Quinidine Quinidine The metabolism of Quinidine can be increased when combined with Sulfinpyrazone.
Rifampin Rifampin Rifampicin may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Valproic Acid Valproic Acid The metabolism of Valproic acid can be decreased when combined with Sulfinpyrazone.
Tamoxifen Tamoxifen The metabolism of Sulfinpyrazone can be increased when combined with Tamoxifen.
Mitomycin Mitomycin The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Mitomycin.
Methimazole Methimazole The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Methimazole.
Propylthiouracil Propylthiouracil The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Propylthiouracil.
Chlorpropamide Chlorpropamide The metabolism of Chlorpropamide can be decreased when combined with Sulfinpyrazone.
Tolbutamide Tolbutamide The metabolism of Tolbutamide can be decreased when combined with Sulfinpyrazone.
Tolazamide Tolazamide The metabolism of Tolazamide can be decreased when combined with Sulfinpyrazone.
Dextromethorphan Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Sulfinpyrazone.
Brompheniramine Brompheniramine The metabolism of Brompheniramine can be increased when combined with Sulfinpyrazone.
Methyclothiazide Methyclothiazide The therapeutic efficacy of Sulfinpyrazone can be decreased when used in combination with Methyclothiazide.
Hydrochlorothiazide Hydrochlorothiazide The therapeutic efficacy of Sulfinpyrazone can be decreased when used in combination with Hydrochlorothiazide.
Disulfiram Disulfiram Disulfiram may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Nortriptyline Nortriptyline The metabolism of Nortriptyline can be increased when combined with Sulfinpyrazone.
Spironolactone Spironolactone Spironolactone may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Mercaptopurine Mercaptopurine The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Mercaptopurine.
Allopurinol Allopurinol The excretion of Sulfinpyrazone can be increased when combined with Allopurinol.
Fluorouracil Injection Fluorouracil Injection The metabolism of Fluorouracil can be decreased when combined with Sulfinpyrazone.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Cephalexin Cephalexin The metabolism of Cephalexin can be increased when combined with Sulfinpyrazone.
Dacarbazine Dacarbazine The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Dacarbazine.
Ketoconazole Ketoconazole Ketoconazole may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be increased when combined with Sulfinpyrazone.
Vincristine Injection Vincristine Injection The metabolism of Sulfinpyrazone can be increased when combined with Vincristine.
Dipyridamole Dipyridamole The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Dipyridamole.
Vinblastine Vinblastine The metabolism of Sulfinpyrazone can be increased when combined with Vinblastine.
Metoprolol Metoprolol The metabolism of Metoprolol can be increased when combined with Sulfinpyrazone.
Aspirin Aspirin Acetylsalicylic acid may increase the antiplatelet activities of Sulfinpyrazone.
Salsalate Salsalate The risk or severity of bleeding can be increased when Salsalate is combined with Sulfinpyrazone.
Chlorambucil Chlorambucil The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Chlorambucil.
Trimethoprim Trimethoprim The metabolism of Trimethoprim can be decreased when combined with Sulfinpyrazone.
Diltiazem Diltiazem The metabolism of Diltiazem can be decreased when combined with Sulfinpyrazone.
Nifedipine Nifedipine Nifedipine may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Verapamil Verapamil The metabolism of Verapamil can be decreased when combined with Sulfinpyrazone.
Atenolol Atenolol Atenolol may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Cisplatin Injection Cisplatin Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Cisplatin.
Diflunisal Diflunisal The risk or severity of bleeding can be increased when Diflunisal is combined with Sulfinpyrazone.
Piroxicam Piroxicam The risk or severity of bleeding can be increased when Piroxicam is combined with Sulfinpyrazone.
Streptozocin Streptozocin The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Streptozocin.
Etoposide Etoposide The metabolism of Etoposide can be increased when combined with Sulfinpyrazone.
Glyburide Glyburide Glyburide may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Glipizide Glipizide The metabolism of Glipizide can be decreased when combined with Sulfinpyrazone.
Pentoxifylline Pentoxifylline Pentoxifylline may increase the antiplatelet activities of Sulfinpyrazone.
Ketoprofen Ketoprofen The risk or severity of bleeding can be increased when Ketoprofen is combined with Sulfinpyrazone.
Pimozide Pimozide The metabolism of Pimozide can be increased when combined with Sulfinpyrazone.
Flurbiprofen Flurbiprofen The risk or severity of bleeding can be increased when Flurbiprofen is combined with Sulfinpyrazone.
Amiodarone Amiodarone The metabolism of Amiodarone can be increased when combined with Sulfinpyrazone.
Lovastatin Lovastatin The metabolism of Lovastatin can be decreased when combined with Sulfinpyrazone.
Mesalamine Mesalamine The risk or severity of bleeding can be increased when Mesalazine is combined with Sulfinpyrazone.
Diclofenac Diclofenac The risk or severity of bleeding can be increased when Diclofenac is combined with Sulfinpyrazone.
Fluoxetine Fluoxetine The metabolism of Sulfinpyrazone can be decreased when combined with Fluoxetine.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Interferon alfa-2b.
Clozapine Clozapine The metabolism of Clozapine can be decreased when combined with Sulfinpyrazone.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Sulfinpyrazone.
Ofloxacin Ofloxacin Sulfinpyrazone may decrease the excretion rate of Ofloxacin which could result in a higher serum level.
Fludarabine Injection Fludarabine Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Fludarabine.
Pentostatin Injection Pentostatin Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Pentostatin.
Clarithromycin Clarithromycin Sulfinpyrazone may decrease the excretion rate of Clarithromycin which could result in a higher serum level.
Etodolac Etodolac The risk or severity of bleeding can be increased when Etodolac is combined with Sulfinpyrazone.
Felodipine Felodipine Felodipine may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Nabumetone Nabumetone The risk or severity of gastrointestinal irritation can be increased when Sulfinpyrazone is combined with Nabumetone.
Pravastatin Pravastatin Pravastatin may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Simvastatin Simvastatin The metabolism of Simvastatin can be decreased when combined with Sulfinpyrazone.
Amlodipine Amlodipine The metabolism of Amlodipine can be increased when combined with Sulfinpyrazone.
Teniposide Injection Teniposide Injection The metabolism of Teniposide can be increased when combined with Sulfinpyrazone.
Oxaprozin Oxaprozin The risk or severity of bleeding can be increased when Oxaprozin is combined with Sulfinpyrazone.
Zolpidem Zolpidem The metabolism of Zolpidem can be increased when combined with Sulfinpyrazone.
Doxazosin Doxazosin The metabolism of Doxazosin can be increased when combined with Sulfinpyrazone.
Isradipine Isradipine Isradipine may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Omeprazole Omeprazole The metabolism of Omeprazole can be decreased when combined with Sulfinpyrazone.
Cisapride Cisapride The metabolism of Cisapride can be increased when combined with Sulfinpyrazone.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Sulfinpyrazone.
Venlafaxine Venlafaxine The metabolism of Venlafaxine can be decreased when combined with Sulfinpyrazone.
Famciclovir Famciclovir The metabolism of Famciclovir can be increased when combined with Sulfinpyrazone.
Fluvoxamine Fluvoxamine Fluvoxamine may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Nefazodone Nefazodone Sulfinpyrazone may decrease the excretion rate of Nefazodone which could result in a higher serum level.
Losartan Losartan The metabolism of Losartan can be decreased when combined with Sulfinpyrazone.
Tramadol Tramadol The metabolism of Tramadol can be increased when combined with Sulfinpyrazone.
Vinorelbine Injection Vinorelbine Injection The metabolism of Vinorelbine can be increased when combined with Sulfinpyrazone.
Carboplatin Injection Carboplatin Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Carboplatin.
Lansoprazole Lansoprazole The metabolism of Lansoprazole can be decreased when combined with Sulfinpyrazone.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be increased when combined with Sulfinpyrazone.
Nicardipine Nicardipine The metabolism of Sulfinpyrazone can be decreased when combined with Nicardipine.
Bupropion Bupropion The metabolism of Bupropion can be decreased when combined with Sulfinpyrazone.
Ticlopidine Ticlopidine Ticlopidine may increase the antiplatelet activities of Sulfinpyrazone.
Saquinavir Saquinavir Sulfinpyrazone may decrease the excretion rate of Saquinavir which could result in a higher serum level.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Dalteparin.
Glimepiride Glimepiride The metabolism of Glimepiride can be decreased when combined with Sulfinpyrazone.
Anastrozole Anastrozole The metabolism of Anastrozole can be decreased when combined with Sulfinpyrazone.
Gemcitabine Injection Gemcitabine Injection The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Gemcitabine.
Indinavir Indinavir Indinavir may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Ritonavir Ritonavir The serum concentration of Sulfinpyrazone can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be increased when combined with Sulfinpyrazone.
Clomipramine Clomipramine The metabolism of Clomipramine can be increased when combined with Sulfinpyrazone.
Zafirlukast Zafirlukast The metabolism of Zafirlukast can be decreased when combined with Sulfinpyrazone.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Sulfinpyrazone.
Valsartan Valsartan The metabolism of Valsartan can be decreased when combined with Sulfinpyrazone.
Donepezil Donepezil The metabolism of Donepezil can be decreased when combined with Sulfinpyrazone.
Nelfinavir Nelfinavir Nelfinavir may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Azithromycin Azithromycin The metabolism of Azithromycin can be increased when combined with Sulfinpyrazone.
Loratadine Loratadine Loratadine may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Carvedilol Carvedilol The metabolism of Carvedilol can be decreased when combined with Sulfinpyrazone.
Selegiline Selegiline The metabolism of Selegiline can be decreased when combined with Sulfinpyrazone.
Bicalutamide Bicalutamide The metabolism of Bicalutamide can be increased when combined with Sulfinpyrazone.
Sertraline Sertraline The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Sertraline.
Irbesartan Irbesartan The metabolism of Irbesartan can be decreased when combined with Sulfinpyrazone.
Paroxetine Paroxetine The risk or severity of hemorrhage can be increased when Paroxetine is combined with Sulfinpyrazone.
Citalopram Citalopram The risk or severity of hemorrhage can be increased when Citalopram is combined with Sulfinpyrazone.
Capecitabine Capecitabine The metabolism of Capecitabine can be decreased when combined with Sulfinpyrazone.
Efavirenz Efavirenz The metabolism of Efavirenz can be increased when combined with Sulfinpyrazone.
Sildenafil Sildenafil The metabolism of Sildenafil can be decreased when combined with Sulfinpyrazone.
Pioglitazone Pioglitazone The metabolism of Pioglitazone can be decreased when combined with Sulfinpyrazone.
Celecoxib Celecoxib The risk or severity of bleeding can be increased when Celecoxib is combined with Sulfinpyrazone.
Rosiglitazone Rosiglitazone The metabolism of Rosiglitazone can be decreased when combined with Sulfinpyrazone.
Tolterodine Tolterodine The metabolism of Tolterodine can be decreased when combined with Sulfinpyrazone.
Thalidomide Thalidomide The metabolism of Thalidomide can be decreased when combined with Sulfinpyrazone.
Balsalazide Balsalazide The risk or severity of bleeding can be increased when Balsalazide is combined with Sulfinpyrazone.
Nateglinide Nateglinide The metabolism of Nateglinide can be decreased when combined with Sulfinpyrazone.
Terbinafine Terbinafine The metabolism of Terbinafine can be decreased when combined with Sulfinpyrazone.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists